⌘K

Login Start Free

Home/Filings/4/0001593968-23-001008

4//SEC Filing

Mayo Stephen 4

Accession 0001593968-23-001008

CIK 0001737287other

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:57 PM ET

Size

5.0 KB

Accession

0001593968-23-001008

Insider Transaction Report

Form 4

Period: 2023-06-13

Allogene Therapeutics, Inc.ALLO

Director

Transactions

Award
Stock Option (Right to Buy)
2023-06-13+116,120→ 116,120 total
Exercise: $5.70Exp: 2033-06-13→ Common Stock (116,120 underlying)

Footnotes (1)

[F1]Vesting in 12 equal monthly installments

Documents

1 file

4
primary_01.xmlPrimary
PRIMARY DOCUMENT

Issuer

Allogene Therapeutics, Inc.

CIK 0001737287

Entity typeother

Related Parties

1

filerCIK 0001849061

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 4:57 PM ET
Size: 5.0 KB

View on SEC.gov